Clinical trial agreement negotiation, with every site redline answered from your playbook
Every site redline answered from the playbook and past agreements, and signed inside 45 days.
See one case, screen by screen ↓A site’s redline comes back as a Word file full of tracked changes and margin comments. Each one has to be read against the CTA playbook — indemnification, subject injury, publication, IP, confidentiality, insurance, payment terms — and answered with the right position: accept, counter with a fallback, or escalate. Then someone has to remember what this institution signed last time, check the injury wording against the approved consent form, and check the start-up fee against fair market value.
Most of that work is lookup, not judgement. Contracts managers search old agreements, forward clauses to legal that the playbook already answers, and wait on budget for fees that are plainly in or out of range. Rounds multiply, the agreement sits on someone’s desk, and the site cannot activate — while first patient in stays fixed on the calendar.
Estimated split for one site agreement, in days, by hand and with the solution.
Six specialist agents read, check and draft a reply to every change; the contracts manager decides each clause.
Marlowe University Hospital sends its round 2 redline of the VLT-302 clinical trial agreement at 08:12, on day 19 of the 45-day clock. Here is what happens next, screen by screen, in the working solution.
Priya opens the solution to 11 site agreements open across 3 studies, 4 of them her move today. The signature runway shows each agreement’s days since the template went out, coloured by who held the pen, against a dashed 45-day target. At the top of her list: Marlowe’s round 2 redline, 12 changes, not reviewed yet.
First patient in, VLT-302, Dec 1: “7 of 9 open VLT-302 agreements on track … At risk: Saint-Clair (Day 29, waiting on us) and Rheinfeld (indemnification with legal).”
Marlowe_VLT-302_CTA_round2_redline.docx, from Rachel Kim in Marlowe’s research contracts office: 12 tracked changes and 6 comments. The struck-through indemnity carve-out and the rewritten subject-injury clause are right there on page 3. The sources panel stays empty until the agents have read it.
“Agents read, classify and draft — you decide every reply.”
The Redline reader reads all 14 pages and maps every change to a section of template v2026.1. The Playbook checker places each change on the position ladder — preferred, fallback 1, fallback 2, walk-away. The Precedent finder pulls the CRV-118 agreement Marlowe signed with us on Mar 14, 2024 and finds 5 matching clauses.
Every step is shown as it runs, with how long it took.
Seven changes can be accepted as sent, three get a counter with an approved fallback, two go to a decision owner. Five of the twelve clauses match what Marlowe already signed — indemnification, subject injury, publication, confidentiality and governing law are proposed exactly as signed. The summary lists the five that need judgement.
“12 replies drafted for Marlowe — 7 accept, 3 counter with an approved fallback, 2 for a decision owner.”
Marlowe wants Northwind Bio to pay for any injury “occurring during the Study Subject’s participation”, not only injuries the study caused, and has struck the insurance-first condition. The ladder shows Marlowe’s ask past the walk-away, what Marlowe signed in 2024 at Fallback 1, and the drafted reply at Fallback 1 — drop insurance-first, keep causation.
Rachel Kim’s comment: “Repeating our round 1 comment: our IRB will not approve consent language that leaves participants with bills for anything that happens while they are on study.”
The checker opens Marlowe’s VLT-302 informed consent form v3.0, IRB approved Sep 2, 2026: it promises treatment costs for injuries “as a direct result of taking the study drug or of procedures done for the study”, and “You will not be asked to use your own insurance first.” Marlowe rejected this counter in round 1, so rule ESC-01 sends it to legal. Priya clicks Send to legal.
“Sent to Omar Haddad — the counter is ready for the response.”
Payment in 30 days is Fallback 1, so the drafted reply accepts it. The $18,000 start-up fee is above the fair-market-value range of $8,000–12,500 for a US academic dermatology site, so it goes to Lena Ortiz with $12,500 proposed — the top of the range. Priya then agrees the ten in-playbook replies in one step: 10 of 12 agreed, 2 with owners.
Rachel Kim’s comment: “Fee reflects our updated start-up cost schedule, effective July 2026.”
The response is built from Priya’s decisions: 7 accepted, 3 of our changes, 2 under review. Each change carries a margin note — “Fallback wording — the same text we signed with Marlowe for CRV-118 in March 2024. Safety deviations stay covered.” The cover email to Rachel Kim, copied to Dr. Elena Varga and Sam Patel, tells Marlowe that subject injury and payment terms are under internal review, with a reply by Oct 10.
“Nothing reaches the site until you send it. Every comment cites the playbook or an agreement Marlowe already signed.”
Priya sends the response redline and the Exhibit B budget. It goes as Priya Raman, and the version sent, the comments and her decisions are kept on the record. The clock now runs on Marlowe’s side; a reminder is drafted after 10 days.
Omar sees the exception with the site’s ask, our walk-away, the risks — “Consent form mismatch if accepted”, “Rejected once already” — and a recommendation: hold causation, accept dropping insurance-first, offer a call with Marlowe’s IRB liaison. He approves it, and the decision is recorded with his name, date and time.
“Decision recorded — Priya applies it in Marlowe’s next round.”
The same redline, seen by the people who carry it — what their week looked like, and what it looks like now.
Six specialist agents read, check and draft a reply to every change; the contracts manager decides each clause.
Reads the site’s Word redline — tracked changes and margin comments — and maps every change to a template clause.
Places every change on the position ladder — preferred, fallback 1, fallback 2, walk-away — and applies the country rules.
Finds what was signed with the same institution or network before, clause by clause, and highlights the signed text.
Checks subject-injury, record, sample and data clauses against the protocol and the site’s approved consent form.
Compares fees and payment terms with the fair-market-value benchmark and routes anything outside it to the budget owner.
Drafts the reply for each clause, routes exceptions to their owners, then builds the response redline and cover email from the decisions.
Decides each clause. The agents propose; a named person decides.
Ask about any site agreement, clause or precedent — or tell it what to change. Answers cite the playbook and the signed agreements.
Which agreements are waiting on us?
Four are your move today: Marlowe (round 2 redline, 12 changes, day 19), Saint-Clair (legal decided — apply it, day 29), Fernhill (1 clause to decide, day 22) and San Aurelio (3 clauses to decide, day 8). Saint-Clair is closest to the 45-day target — one click applies Omar’s decision.
What did we agree with Marlowe on publication in 2024?
In the CRV-118 agreement signed on Mar 14, 2024, Marlowe accepted a 45-day review before submission and kept the 60-day patent delay. Their round 2 redline asks for 30 days and no patent delay — the drafted reply goes back to the 2024 terms, which is also Fallback 1 in the playbook.
Which sites will miss the 45-day target?
Two open agreements are past or close to it: Copperline on day 52, with the site reviewing our IP counter, and Rheinfeld on day 34, with the liability cap with legal. Approving the Rheinfeld recommendation today keeps it inside the target; Copperline needs a call with the site’s technology transfer office.
Add a rule: accept 5-year confidentiality automatically
Done. Confidentiality changes from 7 to 5 years are now accepted automatically — it is Fallback 1, conceded in 46% of negotiations this year. The rule is a new playbook draft (v4.3) waiting for Dana Okafor’s approval; until then it applies as a proposal you confirm.
13 screens from the working solution, on its sample data. Pick one to see it large.
Who decides, how long the clock runs and what the agents may do are settings — and the playbook stays yours, versioned and approved by its owner.
| Setting | Default | Choose from |
|---|---|---|
| Legal decision owner | Omar Haddad | Omar Haddad · Dana Okafor |
| Budget decision owner | Lena Ortiz | Lena Ortiz · Sam Patel |
| Target, template to signature | 45 days | Set in days, − / + |
| Remind the site after | 10 days | Set in days, − / + |
| Accept changes we already signed with this site in the last 24 months | On | On · Off |
| Send a clause rejected twice to legal | On | On · Off |
| Send a response without a person | Always a person | Always a person |
| Signing order | Institution, then Northwind Bio | Institution, then Northwind Bio · Northwind Bio, then institution |
Every figure is labelled: a target the solution is built to, an estimate, a typical published result, or a proven one.
“demo” = seen in the working solution, on its sample agreements · “target” = the design goal, measured in the live solution · “estimated” = our estimate · “typical” = published research-contracting benchmarks (2025) — industry average of 90+ days from template to signature. People and institutions named on this page are characters in the working solution.
Software that reads a site’s redline of your clinical trial agreement, checks every change against your CTA playbook and what that institution signed before, and drafts a reply for each clause. The Clinical Trial Agreement Negotiation Copilot does this with six agents; the contracts manager decides every clause and sends the response.
The Playbook checker places each change on your position ladder — preferred, fallback 1, fallback 2, walk-away — and cites the rule. Changes inside the pre-approved positions are proposed as accept or as a counter with the fallback language; anything past the walk-away, or a clause the site has rejected twice, goes to its decision owner.
Yes. The Precedent finder looks up executed, fully signed agreements with the same institution, clause by clause, and shows the signed text and its date. In the Marlowe example, five of twelve clauses were proposed exactly as Marlowe signed them in 2024.
Yes. The Protocol & consent checker compares subject-injury, record, sample and data clauses with the protocol and the site’s approved consent form, flags any promise the consent form does not make, and leaves wording conflicts to the medical owner.
The Budget checker compares fees and payment terms with your fair-market-value benchmark. It never approves a fee above the range; those go to the budget owner with a proposed counter.
Yes. Agents read, classify and draft; a named contracts manager decides every reply and sends every response — sending without a person is not an option. Exceptions are decided by named legal, budget or medical owners, and the playbook changes only when its owner approves a new version.
Yes. The positions per clause, the country rules (for example the UK model agreement or the French convention unique), the decision owners, the 45-day target, the reminder interval and the signing order are all yours to set.
The Agentic Solution Engine builds and deploys it from your requirements — your CTA template and playbook, country rules and a sample of executed agreements and past redlines — and it goes live once every quality gate has passed. We will walk you through it on your own redlines first.
A trial synopsis becomes a checked first-draft protocol in days, in your own approved language.
1-min filmTMF CheckEvery trial document is read, filed in the right place and checked, so the file is inspection-ready every day.
1-min filmCSR WriterResults sections and patient narratives are drafted within days of database lock, every number linked to its table.
1-min filmWe’ll run the Negotiation Copilot on a sample of your own playbook and past redlines.